Dai-ichi Life Insurance Company’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17M | Buy |
77,033
+7,386
| +11% | +$2.04M | 0.4% | 61 |
|
|
2026
Q1 | $20.6M | Sell |
69,647
-10,402
| -13% | -$3.09M | 0.59% | 40 |
|
|
2025
Q4 | $21.9M | Sell |
80,049
-12,215
| -13% | -$3.32M | 0.56% | 39 |
|
|
2025
Q3 | $24.9M | Buy |
92,264
+36,598
| +66% | +$9.96M | 0.62% | 38 |
|
|
2025
Q2 | $15.3M | Buy |
55,666
+4,415
| +9% | +$1.2M | 0.43% | 59 |
|
|
2025
Q1 | $13.6M | Sell |
51,251
-851
| -2% | -$210K | 0.4% | 65 |
|
|
2024
Q4 | $12.1M | Buy |
52,102
+859
| +2% | +$198K | 0.33% | 68 |
|
|
2024
Q3 | $11.3M | Sell |
51,243
-7,527
| -13% | -$1.56M | 0.29% | 85 |
|
|
2024
Q2 | $11.6M | Buy |
58,770
+4,159
| +8% | +$859K | 0.28% | 90 |
|
|
2024
Q1 | $11.8M | Sell |
54,611
-12,700
| -19% | -$2.67M | 0.27% | 90 |
|
|
2023
Q4 | $14.2M | Buy |
67,311
+31,535
| +88% | +$6.73M | 0.29% | 77 |
|
|
2023
Q3 | $7.16M | Hold |
35,776
| – | – | 0.16% | 132 |
|
|
2023
Q2 | $6.63M | Hold |
35,776
| – | – | 0.14% | 137 |
|
|
2023
Q1 | $6.85M | Sell |
35,776
-6,862
| -16% | -$1.24M | 0.15% | 133 |
|
|
2022
Q4 | $7.17M | Hold |
42,638
| – | – | 0.17% | 124 |
|
|
2022
Q3 | $7.55M | Hold |
42,638
| – | – | 0.19% | 108 |
|
|
2022
Q2 | $8.73M | Sell |
42,638
-11,654
| -21% | -$2.47M | 0.19% | 101 |
|
|
2022
Q1 | $12.9M | Hold |
54,292
| – | – | 0.21% | 106 |
|
|
2021
Q4 | $12.4M | Hold |
54,292
| – | – | 0.16% | 120 |
|
|
2021
Q3 | $10.5M | Sell |
54,292
-804
| -1% | -$163K | 0.14% | 127 |
|
|
2021
Q2 | $11.7M | Buy |
55,096
+5,351
| +11% | +$1.13M | 0.15% | 129 |
|
|
2021
Q1 | $10.2M | Sell |
49,745
-1,943
| -4% | -$383K | 0.14% | 120 |
|
|
2020
Q4 | $9.41M | Buy |
51,688
+9,358
| +22% | +$1.59M | 0.14% | 123 |
|
|
2020
Q3 | $7.08M | Buy |
42,330
+5,214
| +14% | +$878K | 0.13% | 133 |
|
|
2020
Q2 | $6.03M | Buy |
37,116
+401
| +1% | +$71.9K | 0.14% | 131 |
|
|
2020
Q1 | $6.35M | Sell |
36,715
-29,810
| -45% | -$5.93M | 0.24% | 100 |
|
|
2019
Q4 | $13.4M | Sell |
66,525
-37,784
| -36% | -$7.75M | 0.3% | 78 |
|
|
2019
Q3 | $22M | Buy |
104,309
+33,691
| +48% | +$7.04M | 0.53% | 46 |
|
|
2019
Q2 | $13.7M | Sell |
70,618
-51,845
| -42% | -$9.56M | 0.33% | 75 |
|
|
2019
Q1 | $20.2M | Buy |
122,463
+3,613
| +3% | +$639K | 0.5% | 45 |
|
|
2018
Q4 | $22.4M | Sell |
118,850
-17,000
| -13% | -$3.14M | 0.61% | 35 |
|
|
2018
Q3 | $23.1M | Sell |
135,850
-14,983
| -10% | -$2.52M | 0.5% | 35 |
|
|
2018
Q2 | $24.7M | Buy |
150,833
+49,121
| +48% | +$8.02M | 0.59% | 34 |
|
|
2018
Q1 | $16.5M | Buy |
101,712
+18,118
| +22% | +$2.88M | 0.34% | 63 |
|
|
2017
Q4 | $12.2M | Buy |
83,594
+78,689
| +1,604% | +$11.2M | 0.24% | 85 |
|
|
2017
Q3 | $666K | Buy |
4,905
+296
| +6% | +$37.4K | 0.01% | 405 |
|
|
2017
Q2 | $577K | Sell |
4,609
-1,474
| -24% | -$176K | 0.01% | 423 |
|
|
2017
Q1 | $723K | Hold |
6,083
| – | – | 0.02% | 411 |
|
|
2016
Q4 | $702K | Buy |
+6,083
| New | +$677K | 0.02% | 429 |
|
Other funds holding CME
Dai-ichi Life Insurance Company's CME Position: Q2 2026 in Review
Dai-ichi Life Insurance Company increased its CME Group (CME) stake by 11% in Q2 2026, buying an estimated $2.04M and bringing the position to 77,033 shares worth $17M. The position accounts for 0.4% of the portfolio, ranked #61.
Dai-ichi Life Insurance Company first reported a position in CME in Q4 2016 and has held it in 39 quarters since. The position peaked at $24.9M in Q3 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Dai-ichi Life Insurance Company held 77,033 shares of CME Group worth $17M as of Q2 2026.
- Dai-ichi Life Insurance Company bought 7,386 CME Group shares in Q2 2026, an estimated $2.04M.
- CME Group made up 0.4% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #61 holding.
- Dai-ichi Life Insurance Company first reported a position in CME Group in Q4 2016 and has held it in 39 quarters since.
- Dai-ichi Life Insurance Company's CME Group position peaked at $24.9M in Q3 2025.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.